266 related articles for article (PubMed ID: 35811052)
21. Modulation and proteomic changes on the heme pathway following treatment with 5-aminolevulinic acid.
Sansaloni-Pastor S; Varesio E; Lange N
J Photochem Photobiol B; 2022 Aug; 233():112484. PubMed ID: 35671620
[TBL] [Abstract][Full Text] [Related]
22. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
23. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
24. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
25. Methadone enhances the effectiveness of 5-aminolevulinic acid-based photodynamic therapy for squamous cell carcinoma and glioblastoma in vitro.
Shi L; Buchner A; Pohla H; Pongratz T; Rühm A; Zimmermann W; Gederaas OA; Zhang L; Wang X; Stepp H; Sroka R
J Biophotonics; 2019 Oct; 12(10):e201800468. PubMed ID: 31140754
[TBL] [Abstract][Full Text] [Related]
26. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y
Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103
[TBL] [Abstract][Full Text] [Related]
27. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
28. δ-Aminolevulinic acid and its methyl ester induce the formation of Protoporphyrin IX in cultured sensory neurones.
Novak B; Schulten R; Lübbert H
Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):583-602. PubMed ID: 21947250
[TBL] [Abstract][Full Text] [Related]
29. Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma.
Anand S; Rollakanti KR; Horst RL; Hasan T; Maytin EV
Photochem Photobiol; 2014; 90(5):1126-35. PubMed ID: 24807677
[TBL] [Abstract][Full Text] [Related]
30. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
Mansi M; Howley R; Chen B
Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
[TBL] [Abstract][Full Text] [Related]
31. The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid.
Hayashi M; Fukuhara H; Inoue K; Shuin T; Hagiya Y; Nakajima M; Tanaka T; Ogura S
PLoS One; 2015; 10(3):e0122351. PubMed ID: 25822972
[TBL] [Abstract][Full Text] [Related]
32. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
[TBL] [Abstract][Full Text] [Related]
33. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
34. Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
Nakayama T; Nozawa N; Kawada C; Yamamoto S; Ishii T; Ishizuka M; Namikawa T; Ogura SI; Hanazaki K; Inoue K; Karashima T
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101893. PubMed ID: 32592910
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.
Sinha AK; Anand S; Ortel BJ; Chang Y; Mai Z; Hasan T; Maytin EV
Br J Cancer; 2006 Aug; 95(4):485-95. PubMed ID: 16868543
[TBL] [Abstract][Full Text] [Related]
36. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma.
Zhao SG; Chen XF; Wang LG; Yang G; Han DY; Teng L; Yang MC; Wang DY; Shi C; Liu YH; Zheng BJ; Shi CB; Gao X; Rainov NG
Ann Surg Oncol; 2013 Dec; 20(13):4379-88. PubMed ID: 22688660
[TBL] [Abstract][Full Text] [Related]
38. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
39. Neurotransmitter transporter family including SLC6A6 and SLC6A13 contributes to the 5-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin IX and photodamage, through uptake of ALA by cancerous cells.
Tran TT; Mu A; Adachi Y; Adachi Y; Taketani S
Photochem Photobiol; 2014; 90(5):1136-43. PubMed ID: 24842606
[TBL] [Abstract][Full Text] [Related]
40. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
